DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Derosa G, Cicero AF, D’Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Ferrari I, Gravina A, Fogari R.
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-α
Hypertens Res 2006; 29: 849-856
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.